Have a question or topic idea for The Life Science Report? Submit it here.
The Most Notable Product Approvals of 2023
Guests: Pete Bak and Christian Thienel
Airdate: January 30, 2024
Taking a year-in-review approach, Back Bay’s strategic advisors discuss notable product approvals from 2023, including the most recent mid-December ’23 CRISPR and Vertex approval of Exa-cel, Biogen and Sage’s approval of the first oral treatment earlier this year for women with postpartum depression and Genmab and Roche’s approval for the CD20 bispecific in lymphoma.
This year on the podcast we covered a wide range of topics featuring stories from the frontline of healthcare development to the rising trends in cardiology to the transactional landscape of antibody drug conjugates. We always welcome listener questions or topics you’d like to learn more about. You can listen to previous episodes or submit your inquiries here.
Subscribe:
Apple Podcasts | Libsyn | Spotify | Stitcher